254 related articles for article (PubMed ID: 6357025)
1. In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens.
Goldstein FW; Gutmann L; Williamson R; Collatz E; Acar JF
Ann Microbiol (Paris); 1983; 134A(3):329-37. PubMed ID: 6357025
[TBL] [Abstract][Full Text] [Related]
2. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)].
Schmid B; Kayser FH
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353
[TBL] [Abstract][Full Text] [Related]
3. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)].
Schmid B; Kayser FH
Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354
[TBL] [Abstract][Full Text] [Related]
4. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
[TBL] [Abstract][Full Text] [Related]
5. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
Filloy L; Serrano D; Borjas E
Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy of a synergistic combination of cefotaxime and amikacin against multiresistant Pseudomonas and Serratia infections.
Maslow MJ; Simberkoff MS; Rahal JJ
J Antimicrob Chemother; 1985 Aug; 16(2):227-34. PubMed ID: 3934125
[TBL] [Abstract][Full Text] [Related]
8. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
Traub WH; Bauer D
Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the ability of newer beta-lactam antibiotics to select resistant mutants from Serratia marcescens after mutagenesis with nitrosoguanidine.
Vuye A; Baert E; Kersters K; Declerck D; Vanhaecke E; Pijck J
Arzneimittelforschung; 1989 Apr; 39(4):424-7. PubMed ID: 2502123
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide recovery restores susceptibility levels towards beta-lactams in Serratia marcescens.
Palomar J; Puig M; Montilla R; Lorén JG; Viñas M
Microbios; 1995; 82(330):21-6. PubMed ID: 7540714
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of severe infections: should one always administer an aminoglycoside?].
Cometta A; Baumgartner JD
Schweiz Med Wochenschr Suppl; 1996; 76():28S-33S. PubMed ID: 8677416
[TBL] [Abstract][Full Text] [Related]
12. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
[TBL] [Abstract][Full Text] [Related]
13. Characterization of imipenem-resistant Serratia marcescens producing IMP-type and TEM-type beta-lactamases encoded on a single plasmid.
Zhao WH; Hu ZQ; Chen G; Matsushita K; Fukuchi K; Shimamura T
Microbiol Res; 2007; 162(1):46-52. PubMed ID: 16875810
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside/beta-lactam combinations in clinical practice.
Leibovici L; Paul M
J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
[TBL] [Abstract][Full Text] [Related]
15. Serratial bacteremia in the surgical patient.
Fry DE; Fry RV; Shlaes DM
Am Surg; 1987 Aug; 53(8):438-41. PubMed ID: 3300452
[TBL] [Abstract][Full Text] [Related]
16. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
[TBL] [Abstract][Full Text] [Related]
17. [Neonatal septicemia due to Pneumococcus resistant to beta-lactam antibiotics].
Devaux AM; Barre V; Blanc T; Nouvellon M; Ensel P
Arch Fr Pediatr; 1993 Feb; 50(2):131-3. PubMed ID: 8343019
[TBL] [Abstract][Full Text] [Related]
18. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
Hechler U; van den Weghe M; Martin HH; Frère JM
J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
[TBL] [Abstract][Full Text] [Related]
19. [Serratia marcescens infection in children in the light of our observations with special reference to changes in sensitivity to commonly used antibiotics].
Fracka B; Krupińska-Sanecka I; Ziółkowska H; Rudzińska M; Marusak T; Marconi T; Kulerski M; Sieniawska M
Pol Tyg Lek; 1987 Aug 3-10; 42(31-32):942-6. PubMed ID: 3317319
[No Abstract] [Full Text] [Related]
20. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
